Riverside Research Institute, Beth Israel Deaconess Medical Center, Rutgers University, and the General Electric Corporation propose to undertake an Academic-Industrial Partnership study to improve prostate- cancer (PCA) imaging markedly and thereby improve prostate-biopsy guidance to detect PCa;enhance monitoring, surveillance, and treatment of PCa;and enable planning and execution of focal PCa therapy. The project is highly significant because it addresses a major health problem in the United States and other developed countries. The project will overcome the current inability of established clinical-imaging method to image PCa reliably by combining the capabilities of advanced ultrasound (US) and magnetic-resonance (MR) techniques in a clinically effective manner. The proposed approach will exploit the sensitivity of US to mechanical properties of tissue on a microscopic scale with the sensitivity of MR to chemical constituents of tissue and its ability to sense blood distribution. Each of these modalities senses different and independent properties of tissue and has shown encouraging potential for improved imaging of PCa when used alone;combining parameters derived from each modality can provide far superior sensitivity and specificity for PCa. We will combine US and MR parameters using advanced classifiers such as artificial neural networks and support-vector machines. These classifiers already have produced ROC-curve areas of 0.91 for advanced US methods, and the MR methods have demonstrated equivalent ROC-curve areas in many studies. We will embody the combined capabilities in specifications for a prototype imaging system that can generate prostate tissue-typing images (TTIs) in real-time for targeting biopsies or planning treatment in the operating room or in an off-line setting. The latest Logiq E9 instrument currently being produced by GE already has a capability for fusing previously obtained MR images with US images in real time, which provides an existing framework for combining US and MR parameters and generating real-time TTIs. Successfully generating reliable prostate TTIs based on combined US and MR parameters will represent a quantum advance in PCa management by enabling significant improvements in the diagnosis and treatment of PCa.

Public Health Relevance

Riverside Research Institute, Beth Israel Deaconess Medical Center, Rutgers University, and the General Electric Corporation propose to undertake an Academic-Industrial Partnership study to improve prostate- cancer (PCA) imaging markedly and thereby improve prostate-biopsy guidance;enhance monitoring, surveillance, and treatment of PCa;and enable planning and execution of focal PCa therapy. The project will combine attributes of advanced ultrasound and magnetic-resonance techniques and embody them in a prototype imaging system capable of generating novel tissue-type images that reliably depict PCa in real-time.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA140772-02
Application #
8123232
Study Section
Special Emphasis Panel (ZRG1-SBIB-U (50))
Program Officer
Baker, Houston
Project Start
2010-08-09
Project End
2015-06-30
Budget Start
2011-07-01
Budget End
2012-06-30
Support Year
2
Fiscal Year
2011
Total Cost
$639,137
Indirect Cost
Name
Riverside Research Institute
Department
Type
DUNS #
046822615
City
New York
State
NY
Country
United States
Zip Code
10038
Lee, George; Veltri, Robert W; Zhu, Guangjing et al. (2017) Nuclear Shape and Architecture in Benign Fields Predict Biochemical Recurrence in Prostate Cancer Patients Following Radical Prostatectomy: Preliminary Findings. Eur Urol Focus 3:457-466
Ginsburg, Shoshana B; Algohary, Ahmad; Pahwa, Shivani et al. (2017) Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study. J Magn Reson Imaging 46:184-193
Wan, Tao; Bloch, B Nicolas; Plecha, Donna et al. (2016) A Radio-genomics Approach for Identifying High Risk Estrogen Receptor-positive Breast Cancers on DCE-MRI: Preliminary Results in Predicting OncotypeDX Risk Scores. Sci Rep 6:21394
Litjens, Geert J S; Elliott, Robin; Shih, Natalie N C et al. (2016) Computer-extracted Features Can Distinguish Noncancerous Confounding Disease from Prostatic Adenocarcinoma at Multiparametric MR Imaging. Radiology 278:135-45
Xu, Jun; Xiang, Lei; Liu, Qingshan et al. (2016) Stacked Sparse Autoencoder (SSAE) for Nuclei Detection on Breast Cancer Histopathology Images. IEEE Trans Med Imaging 35:119-30
Tiwari, P; Prasanna, P; Wolansky, L et al. (2016) Computer-Extracted Texture Features to Distinguish Cerebral Radionecrosis from Recurrent Brain Tumors on Multiparametric MRI: A Feasibility Study. AJNR Am J Neuroradiol 37:2231-2236
Ginsburg, Shoshana B; Taimen, Pekka; Merisaari, Harri et al. (2016) Patient-specific pharmacokinetic parameter estimation on dynamic contrast-enhanced MRI of prostate: Preliminary evaluation of a novel AIF-free estimation method. J Magn Reson Imaging 44:1405-1414
Penzias, Gregory; Janowczyk, Andrew; Singanamalli, Asha et al. (2016) AutoStitcher: An Automated Program for Efficient and Robust Reconstruction of Digitized Whole Histological Sections from Tissue Fragments. Sci Rep 6:29906
Prasanna, Prateek; Tiwari, Pallavi; Madabhushi, Anant (2016) Co-occurrence of Local Anisotropic Gradient Orientations (CoLlAGe): A new radiomics descriptor. Sci Rep 6:37241
Ginsburg, Shoshana B; Lee, George; Ali, Sahirzeeshan et al. (2016) Feature Importance in Nonlinear Embeddings (FINE): Applications in Digital Pathology. IEEE Trans Med Imaging 35:76-88

Showing the most recent 10 out of 71 publications